Published in Clin Respir J on January 01, 2010
Vulnerable COPD patients with comorbidities: the role of roflumilast. Ther Clin Risk Manag (2014) 0.98
Time trends for alendronate prescription practices in women with chronic obstructive pulmonary disease and women exposed to systemic glucocorticoids. Osteoporos Int (2012) 0.75
The Danish National Prescription Registry. Scand J Public Health (2011) 6.07
Fracture risk and zoledronic acid therapy in men with osteoporosis. N Engl J Med (2012) 3.51
Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study. Arch Intern Med (2007) 2.85
Large-scale analysis of association between LRP5 and LRP6 variants and osteoporosis. JAMA (2008) 2.52
Selective serotonin reuptake inhibitors and the risk of stroke: a population-based case-control study. Stroke (2002) 1.86
Persistence of antimuscarinic drug use. Eur J Clin Pharmacol (2008) 1.80
Differing effects of PTH 1-34, PTH 1-84, and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: an 18-month open-labeled observational study using HR-pQCT. J Bone Miner Res (2013) 1.78
Hip fracture patients at risk of second hip fracture: a nationwide population-based cohort study of 169,145 cases during 1977-2001. J Bone Miner Res (2009) 1.76
Incidence rate of community-acquired sepsis among hospitalized acute medical patients-a population-based survey. Crit Care Med (2015) 1.75
Risk of stroke associated with nonsteroidal anti-inflammatory drugs: a nested case-control study. Stroke (2003) 1.74
Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial. Arthritis Rheum (2008) 1.51
Chronic diseases in elderly men: underreporting and underdiagnosis. Age Ageing (2011) 1.48
Hormone replacement therapy increases the risk of cranial meningioma. Eur J Cancer (2013) 1.47
The relationship between health-related quality of life, obesity and testosterone levels in older men. Age Ageing (2013) 1.47
The antiplatelet effect of clopidogrel is not attenuated by statin treatment in stable patients with ischemic heart disease. Thromb Haemost (2005) 1.46
Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials. J Clin Endocrinol Metab (2012) 1.42
Children's relative age in class and use of medication for ADHD: a Danish Nationwide Study. J Child Psychol Psychiatry (2014) 1.41
Risk assessment tools to identify women with increased risk of osteoporotic fracture: complexity or simplicity? A systematic review. J Bone Miner Res (2013) 1.38
First trimester in utero exposure to methylphenidate. Basic Clin Pharmacol Toxicol (2013) 1.38
Risk scoring systems for adults admitted to the emergency department: a systematic review. Scand J Trauma Resusc Emerg Med (2010) 1.34
Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate. J Clin Endocrinol Metab (2007) 1.32
Use of benzodiazepines or benzodiazepine related drugs and the risk of cancer: a population-based case-control study. Br J Clin Pharmacol (2013) 1.32
Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods. Clin Endocrinol (Oxf) (2008) 1.31
Complicated and uncomplicated peptic ulcers in a Danish county 1993-2002: a population-based cohort study. Am J Gastroenterol (2006) 1.28
Fractures in patients with anorexia nervosa, bulimia nervosa, and other eating disorders--a nationwide register study. Int J Eat Disord (2002) 1.27
Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older. J Bone Miner Res (2006) 1.24
Suppression of endogenous testosterone production attenuates the response to strength training: a randomized, placebo-controlled, and blinded intervention study. Am J Physiol Endocrinol Metab (2006) 1.24
Patient education in groups increases knowledge of osteoporosis and adherence to treatment: a two-year randomized controlled trial. Patient Educ Couns (2010) 1.22
Visceral and subcutaneous adipose tissue assessed by magnetic resonance imaging in relation to circulating androgens, sex hormone-binding globulin, and luteinizing hormone in young men. J Clin Endocrinol Metab (2007) 1.21
The validity of self-reported use of hormone replacement therapy among Danish nurses. Acta Obstet Gynecol Scand (2004) 1.19
Classification of myocardial infarction: frequency and features of type 2 myocardial infarction. Am J Med (2013) 1.16
Sequential treatment of severe postmenopausal osteoporosis after teriparatide: final results of the randomized, controlled European Study of Forsteo (EUROFORS). J Bone Miner Res (2009) 1.16
Autosomal dominant osteopetrosis revisited: lessons from recent studies. Eur J Endocrinol (2013) 1.12
Prevalence, awareness, and control of arterial hypertension in Denmark. J Am Soc Hypertens (2008) 1.11
Nurse tele-consultations with discharged COPD patients reduce early readmissions--an interventional study. Clin Respir J (2011) 1.09
Effects on bone geometry, density, and microarchitecture in the distal radius but not the tibia in women with primary hyperparathyroidism: A case-control study using HR-pQCT. J Bone Miner Res (2010) 1.08
Annotations and reflections: pregnancy and paracetamol: methodological considerations on the study of associations between in utero exposure to drugs and childhood neurodevelopment. Basic Clin Pharmacol Toxicol (2014) 1.07
Levels of serotonin, sclerostin, bone turnover markers as well as bone density and microarchitecture in patients with high-bone-mass phenotype due to a mutation in Lrp5. J Bone Miner Res (2011) 1.06
Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients. Gynecol Oncol (2012) 1.06
A randomized trial of laypersons' perception of the benefit of osteoporosis therapy: number needed to treat versus postponement of hip fracture. Clin Ther (2003) 1.06
Birth prevalence and mutation spectrum in danish patients with autosomal recessive albinism. Invest Ophthalmol Vis Sci (2008) 1.05
Esophagitis: incidence and risk of esophageal adenocarcinoma--a population-based cohort study. Am J Gastroenterol (2006) 1.03
The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective. Eur J Clin Pharmacol (2012) 1.03
Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis. Pharmacoepidemiol Drug Saf (2009) 1.03
An association between selective serotonin reuptake inhibitor use and serious upper gastrointestinal bleeding. Clin Gastroenterol Hepatol (2009) 1.01
Incidence and prevalence of nutritional and hereditary rickets in southern Denmark. Eur J Endocrinol (2008) 1.00
Low use and adherence to maintenance medication in chronic obstructive pulmonary disease in the general population. J Gen Intern Med (2014) 1.00
Fracture risk in Danish men with prostate cancer: a nationwide register study. BJU Int (2007) 0.99
Patients with high-bone-mass phenotype owing to Lrp5-T253I mutation have low plasma levels of serotonin. J Bone Miner Res (2010) 0.98
Single-nucleotide polymorphisms in the P2X7 receptor gene are associated with post-menopausal bone loss and vertebral fractures. Eur J Hum Genet (2012) 0.98
Characteristics of undertreatment in COPD in the general population. Chest (2013) 0.97
The use of medication against attention deficit hyperactivity disorder in Denmark: a drug use study from a national perspective. Eur J Clin Pharmacol (2012) 0.97
Fracture risk in perimenopausal women treated with beta-blockers. Calcif Tissue Int (2004) 0.96
Treatment failures after antibiotic therapy of uncomplicated urinary tract infections. A prescription database study. Scand J Prim Health Care (2002) 0.95
Short- and long-term mortality in patients with community-acquired severe sepsis and septic shock. Scand J Infect Dis (2013) 0.95
Bone microarchitecture and estimated strength in 499 adult Danish women and men: a cross-sectional, population-based high-resolution peripheral quantitative computed tomographic study on peak bone structure. Calcif Tissue Int (2013) 0.94
Molecular genetic analysis of the calcium sensing receptor gene in patients clinically suspected to have familial hypocalciuric hypercalcemia: phenotypic variation and mutation spectrum in a Danish population. J Clin Endocrinol Metab (2007) 0.94
Exposure to antiepileptic drugs and the risk of hip fracture: a case-control study. Epilepsia (2008) 0.94
Gender differences in outcome of eating disorders: a retrospective cohort study. Psychiatry Res (2010) 0.94
The risk of missed gastroesophageal cancer diagnoses in users and nonusers of antisecretory medication. Gastroenterology (2005) 0.94
Parathyroidectomy improves bone geometry and microarchitecture in female patients with primary hyperparathyroidism: a one-year prospective controlled study using high-resolution peripheral quantitative computed tomography. J Bone Miner Res (2012) 0.93
Assessment of the global trigger tool to measure, monitor and evaluate patient safety in cancer patients: reliability concerns are raised. BMJ Qual Saf (2013) 0.93
Testosterone therapy increased muscle mass and lipid oxidation in aging men. Age (Dordr) (2011) 0.93
Use of fluroquinolone and risk of Achilles tendon rupture: a population-based cohort study. Eur J Clin Pharmacol (2007) 0.92
Pharmaceutical interventions on prescription problems in a Danish pharmacy setting. Int J Clin Pharm (2011) 0.92
Strontium ranelate reduces the risk of vertebral fractures in patients with osteopenia. J Bone Miner Res (2008) 0.92
Back pain during different sequential treatment regimens of teriparatide: results from EUROFORS. Curr Med Res Opin (2010) 0.91
Geographical variation in DXA bone mineral density in young European men and women. Results from the Network in Europe on Male Osteoporosis (NEMO) study. Bone (2008) 0.91
Mutational analysis of PHEX, FGF23, DMP1, SLC34A3 and CLCN5 in patients with hypophosphatemic rickets. J Hum Genet (2012) 0.91
Long-term use of antiplatelet drugs by stroke patients: a follow-up study based on prescription register data. Eur J Clin Pharmacol (2012) 0.90
Circulating amounts of osteoprotegerin and RANK ligand: genetic influence and relationship with BMD assessed in female twins. Bone (2005) 0.90
Gene expression profiles give insight into the molecular pathology of bone in primary hyperparathyroidism. Bone (2006) 0.90
A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: longitudinal data from the Danish osteoporosis prevention study. J Bone Miner Res (2003) 0.90
Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism. Eur J Endocrinol (2008) 0.90
MTHFR c.677C>T polymorphism as an independent predictor of peak bone mass in Danish men--results from the Odense Androgen Study. Bone (2005) 0.90
Use of SSRIs among Danish children: a nationwide study. Eur Child Adolesc Psychiatry (2014) 0.90
Effects of odanacatib on the radius and tibia of postmenopausal women: improvements in bone geometry, microarchitecture, and estimated bone strength. J Bone Miner Res (2014) 0.88
Sequential analysis of biochemical markers of bone resorption and bone densitometry in multiple myeloma. Haematologica (2004) 0.88
The effect of aromatase inhibitors on bone metabolism. Basic Clin Pharmacol Toxicol (2009) 0.88
Comparison of five biochemical markers of bone resorption in multiple myeloma: elevated pre-treatment levels of S-ICTP and U-Ntx are predictive for early progression of the bone disease during standard chemotherapy. Br J Haematol (2003) 0.88
Utility of testing for monoclonal bands in serum of patients with suspected osteoporosis: retrospective, cross sectional study. BMJ (2005) 0.87
Type of hormone therapy and risk of misclassification at mammography screening. Menopause (2011) 0.87
A MiniReview of the use of hospital-based databases in observational inpatient studies of drugs. Basic Clin Pharmacol Toxicol (2012) 0.87
Skeletal consequences of familial hypocalciuric hypercalcaemia vs. primary hyperparathyroidism. Clin Endocrinol (Oxf) (2009) 0.87
Identification of rare and frequent variants of the CASR gene by high-resolution melting. Clin Chim Acta (2011) 0.87
Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study. Pediatrics (2002) 0.87
Use of opioids in a Danish population-based cohort of cancer patients. J Pain Symptom Manage (2005) 0.86
Changes in bone mineral density (BMD) around the cemented Exeter stem: a prospective study in 18 women with 5 years follow-up. Acta Orthop (2008) 0.86
Phenotype presentation of hypophosphatemic rickets in adults. Calcif Tissue Int (2010) 0.86
Cancer risk in long-term users of vitamin K antagonists: a population-based case-control study. Int J Cancer (2012) 0.86
Bone structure and estimated bone strength in obese patients evaluated by high-resolution peripheral quantitative computed tomography. Calcif Tissue Int (2014) 0.86
A common LRP4 haplotype is associated with bone mineral density and hip geometry in men-data from the Odense Androgen Study (OAS). Bone (2013) 0.85
Osteoporosis and vertebral fractures in men aged 60-74 years. Age Ageing (2012) 0.85
Bioactive insulin-like growth factor (IGF) I and IGF-binding protein-1 in anorexia nervosa. J Clin Endocrinol Metab (2007) 0.85
Assigning exposure duration to single prescriptions by use of the waiting time distribution. Pharmacoepidemiol Drug Saf (2013) 0.85
Long-term use of metformin and colorectal cancer risk in type II diabetics: a population-based case-control study. Cancer Med (2014) 0.85
Handling knowledge on osteoporosis--a qualitative study. Scand J Caring Sci (2012) 0.85
Suppression of testosterone does not blunt mRNA expression of myoD, myogenin, IGF, myostatin or androgen receptor post strength training in humans. J Physiol (2006) 0.85